vs

Side-by-side financial comparison of AbbVie (ABBV) and Bank of America (BAC). Click either name above to swap in a different company.

Bank of America is the larger business by last-quarter revenue ($31.2B vs $16.6B, roughly 1.9× AbbVie). Bank of America runs the higher net margin — 24.1% vs 10.9%, a 13.2% gap on every dollar of revenue. Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs 11.3%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

The Bank of America Corporation is an American multinational investment bank and financial services holding company headquartered at the Bank of America Corporate Center in Charlotte, North Carolina, with investment banking and auxiliary headquarters in Manhattan. The bank was founded by the merger of NationsBank and Bank of America in 1998.

ABBV vs BAC — Head-to-Head

Bigger by revenue
BAC
BAC
1.9× larger
BAC
$31.2B
$16.6B
ABBV
Higher net margin
BAC
BAC
13.2% more per $
BAC
24.1%
10.9%
ABBV
Faster 2-yr revenue CAGR
ABBV
ABBV
Annualised
ABBV
16.2%
11.3%
BAC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABBV
ABBV
BAC
BAC
Revenue
$16.6B
$31.2B
Net Profit
$1.8B
$7.5B
Gross Margin
72.6%
Operating Margin
27.3%
39.9%
Net Margin
10.9%
24.1%
Revenue YoY
10.0%
Net Profit YoY
8354.5%
EPS (diluted)
$1.02
$0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
BAC
BAC
Q4 25
$16.6B
$31.2B
Q3 25
$15.8B
$28.1B
Q2 25
$15.4B
$26.5B
Q1 25
$13.3B
$27.4B
Q4 24
$15.1B
Q3 24
$14.5B
$25.3B
Q2 24
$14.5B
$25.4B
Q1 24
$12.3B
$25.8B
Net Profit
ABBV
ABBV
BAC
BAC
Q4 25
$1.8B
$7.5B
Q3 25
$186.0M
$8.5B
Q2 25
$938.0M
$7.1B
Q1 25
$1.3B
$7.4B
Q4 24
$-22.0M
Q3 24
$1.6B
$6.9B
Q2 24
$1.4B
$6.9B
Q1 24
$1.4B
$6.7B
Gross Margin
ABBV
ABBV
BAC
BAC
Q4 25
72.6%
Q3 25
66.4%
Q2 25
71.8%
Q1 25
70.0%
Q4 24
70.9%
Q3 24
70.9%
Q2 24
70.9%
Q1 24
66.7%
Operating Margin
ABBV
ABBV
BAC
BAC
Q4 25
27.3%
39.9%
Q3 25
12.1%
33.7%
Q2 25
31.7%
29.1%
Q1 25
28.0%
29.7%
Q4 24
-9.9%
Q3 24
26.5%
28.9%
Q2 24
27.6%
29.8%
Q1 24
22.7%
28.1%
Net Margin
ABBV
ABBV
BAC
BAC
Q4 25
10.9%
24.1%
Q3 25
1.2%
30.2%
Q2 25
6.1%
26.9%
Q1 25
9.6%
27.0%
Q4 24
-0.1%
Q3 24
10.8%
27.2%
Q2 24
9.5%
27.2%
Q1 24
11.1%
25.9%
EPS (diluted)
ABBV
ABBV
BAC
BAC
Q4 25
$1.02
$0.96
Q3 25
$0.10
$1.06
Q2 25
$0.52
$0.89
Q1 25
$0.72
$0.90
Q4 24
$-0.03
Q3 24
$0.88
$0.81
Q2 24
$0.77
$0.83
Q1 24
$0.77
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
BAC
BAC
Cash + ST InvestmentsLiquidity on hand
$5.3B
Total DebtLower is stronger
$58.9B
$317.8B
Stockholders' EquityBook value
$-3.3B
$303.2B
Total Assets
$134.0B
$3411.7B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
BAC
BAC
Q4 25
$5.3B
Q3 25
$5.7B
Q2 25
$6.5B
Q1 25
$5.2B
Q4 24
$5.6B
Q3 24
$7.3B
Q2 24
$13.2B
Q1 24
$18.1B
Total Debt
ABBV
ABBV
BAC
BAC
Q4 25
$58.9B
$317.8B
Q3 25
$63.0B
$311.5B
Q2 25
$63.0B
$313.4B
Q1 25
$64.5B
$304.1B
Q4 24
$60.3B
Q3 24
$58.5B
$296.9B
Q2 24
$58.0B
$290.5B
Q1 24
$63.8B
$296.3B
Stockholders' Equity
ABBV
ABBV
BAC
BAC
Q4 25
$-3.3B
$303.2B
Q3 25
$-2.6B
$304.2B
Q2 25
$-183.0M
$299.6B
Q1 25
$1.4B
$295.6B
Q4 24
$3.3B
Q3 24
$6.0B
$296.5B
Q2 24
$6.8B
$293.9B
Q1 24
$8.0B
$293.6B
Total Assets
ABBV
ABBV
BAC
BAC
Q4 25
$134.0B
$3411.7B
Q3 25
$133.9B
$3403.7B
Q2 25
$137.2B
$3441.1B
Q1 25
$136.2B
$3349.4B
Q4 24
$135.2B
Q3 24
$143.4B
$3324.3B
Q2 24
$141.9B
$3258.0B
Q1 24
$148.9B
$3273.8B
Debt / Equity
ABBV
ABBV
BAC
BAC
Q4 25
1.05×
Q3 25
1.02×
Q2 25
1.05×
Q1 25
45.44×
1.03×
Q4 24
18.15×
Q3 24
9.70×
1.00×
Q2 24
8.56×
0.99×
Q1 24
7.97×
1.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
BAC
BAC
Operating Cash FlowLast quarter
$5.2B
$-22.9B
Free Cash FlowOCF − Capex
$4.9B
FCF MarginFCF / Revenue
29.4%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
2.87×
-3.05×
TTM Free Cash FlowTrailing 4 quarters
$17.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
BAC
BAC
Q4 25
$5.2B
$-22.9B
Q3 25
$7.0B
$46.9B
Q2 25
$5.2B
$-9.1B
Q1 25
$1.6B
$-2.2B
Q4 24
$7.0B
Q3 24
$5.4B
Q2 24
$2.3B
Q1 24
$4.0B
$-15.5B
Free Cash Flow
ABBV
ABBV
BAC
BAC
Q4 25
$4.9B
Q3 25
$6.6B
Q2 25
$4.9B
Q1 25
$1.4B
Q4 24
$6.8B
Q3 24
$5.2B
Q2 24
$2.0B
Q1 24
$3.8B
FCF Margin
ABBV
ABBV
BAC
BAC
Q4 25
29.4%
Q3 25
42.1%
Q2 25
31.7%
Q1 25
10.5%
Q4 24
44.7%
Q3 24
35.9%
Q2 24
14.0%
Q1 24
31.3%
Capex Intensity
ABBV
ABBV
BAC
BAC
Q4 25
2.0%
Q3 25
2.4%
Q2 25
1.7%
Q1 25
1.8%
Q4 24
1.9%
Q3 24
1.7%
Q2 24
1.7%
Q1 24
1.6%
Cash Conversion
ABBV
ABBV
BAC
BAC
Q4 25
2.87×
-3.05×
Q3 25
37.76×
5.53×
Q2 25
5.49×
-1.28×
Q1 25
1.27×
-0.30×
Q4 24
Q3 24
3.49×
Q2 24
1.66×
Q1 24
2.95×
-2.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABBV
ABBV

Segment breakdown not available.

BAC
BAC

Other$7.0B22%
Global Wealth And Investment Management Segment$6.6B21%
Global Banking Segment$6.2B20%
Global Markets Segment$5.3B17%
Investment And Brokerage Services Asset Management Fees$4.2B13%
Investment Banking Income Underwriting Income$752.0M2%
Investment Banking Income Financial Advisory Services$590.0M2%
Investment Banking Income Syndication Fees$324.0M1%
Corporate Securities Trading Loansand Other$184.0M1%
Mortgage Trading Loans Mortgage Backed Securities And Asset Backed Securities$31.0M0%
Equity Securities$12.0M0%
Accrued Expensesand Other Liabilities$11.0M0%

Related Comparisons